
Evidence for extending colonoscopy schedule limited
Extending the recommended time between surveillance colonoscopies from 5 years to 10 years for people who have had precursor lesions, such as polyps, removed may increase […]
Extending the recommended time between surveillance colonoscopies from 5 years to 10 years for people who have had precursor lesions, such as polyps, removed may increase […]
A blood test to help guide the treatment of oesophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get […]
A new research project that will improve treatment for the most deadly types of gut cancer has been successful in the latest round of Beat Cancer […]
A new blood test targeting tumor DNA in colorectal (bowel) cancer patients has detected early signs of recurrence of the disease at twice the rate of […]
Dementia, bowel cancer and glaucoma are among diseases to be addressed by researchers at Flinders with National Health and Medical Research Council funding of nearly $5.1 million.
A team of Australian scientists has presented evidence that a new blood test for bowel cancer based on two genes that “leak” into the blood can detect 65 per cent of bowel cancer cases.
Researchers from Flinders University are using newly developed technologies to better understand what causes unexplained gut pain.